Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-06-26 18:49:13 ET · period of report 2026-06-26 · accession 0001258693-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-26 18:49 | 2026-06-26 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $55.21 | -22.2K | 452.5K | -5% | -$1.23M |
| MTI | 2026-06-26 18:49 | 2026-06-26 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $55.23 | -2,000 | 134.2K | -1% | -$110.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-26 | S | D | 6,683 | $54.27 | 468,020 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $53.755 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-06-26 | S | D | 9,137 | $55.27 | 458,883 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $54.755 to $55.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-06-26 | S | D | 6,417 | $56.12 | 452,466 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $55.815 to $56.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-06-26 | S | D | 312 | $54.34 | 134,903 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F6) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 5 | Common | Common Stock | 2026-06-26 | S | D | 356 | $55.23 | 134,547 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F7) The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.51. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F6) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 6 | Common | Common Stock | 2026-06-26 | S | D | 332 | $55.99 | 134,215 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F8) The price reported is a weighted-average price. The shares were sold at prices ranging from $55.88 to $56.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F6) Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| 7 | Common | Common Stock | 2026-06-26 | S | D | 207 | $54.22 | 135,008 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F9) The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F10) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 8 | Common | Common Stock | 2026-06-26 | S | D | 602 | $55.30 | 134,406 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F11) The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F10) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| 9 | Common | Common Stock | 2026-06-26 | S | D | 191 | $56.27 | 134,215 | I By Children's Trust | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. (F12) The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. (F10) Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |